tirzepatide benefits besides weight loss on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial The weight-loss-independent hepatoprotective benefits of

A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer

By adding glucagon receptor activation to GLP-1 and GIP agonism, retatrutide adds a third distinct mechanism to the weight loss equation: not just reduced calorie intake (GLP-1, GIP) but increased calorie burning (glucagon)

These supplements are designed to support nutrition and wellness

These changes are not universal, but they may be more important for people with hypertension, high cholesterol, diabetes, or cardiovascular disease.1 Digestive Changes GLP-1 medications can slow stomach emptying and cause gastrointestinal side effects

The discovery that GLP-2 promotes mucosal growth in the intestine is described, and key findings from both preclinical studies and the GLP-2 clinical development program for short bowel syndrome (SBS) are reviewed

How Microdosing Differs From Standard GLP-1 Use Why Would a Weight Loss Drug Affect Arthritis at All